These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25895400)

  • 1. The adverse effects of mefloquine in deployed military personnel.
    Adshead S
    J R Nav Med Serv; 2014; 100(3):232-7. PubMed ID: 25895400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eye disorders reported with the use of mefloquine (Lariam(®)) chemoprophylaxis--A drug safety database analysis.
    Adamcova M; Schaerer MT; Bercaru I; Cockburn I; Rhein HG; Schlagenhauf P
    Travel Med Infect Dis; 2015; 13(5):400-8. PubMed ID: 26119539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malaria protection in Sierra Leone during the Ebola outbreak 2014/15; The UK military experience with malaria chemoprophylaxis Sep 14-Feb 15.
    Tuck J; Williams J
    Travel Med Infect Dis; 2016; 14(5):471-474. PubMed ID: 27474994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malaria Chemoprophylaxis and Self-Reported Impact on Ability to Work: Mefloquine Versus Doxycycline.
    Terrell AG; Forde ME; Firth R; Ross DA
    J Travel Med; 2015; 22(6):383-8. PubMed ID: 26424621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mefloquine use and hospitalizations among US service members, 2002-2004.
    Wells TS; Smith TC; Smith B; Wang LZ; Hansen CJ; Reed RJ; Goldfinger WE; Corbeil TE; Spooner CN; Ryan MA
    Am J Trop Med Hyg; 2006 May; 74(5):744-9. PubMed ID: 16687673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adverse effects associated with antimalarial chemoprophylaxis].
    Corominas N; Gascón J; Mejías T; Caparrós F; Quintó L; Codina C; Ribas J; Corachán M
    Med Clin (Barc); 1997 May; 108(20):772-5. PubMed ID: 9265081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mefloquine prescriptions in the presence of contraindications: prevalence among US military personnel deployed to Afghanistan, 2007.
    Nevin RL
    Pharmacoepidemiol Drug Saf; 2010 Feb; 19(2):206-10. PubMed ID: 19998269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychiatric reactions with mefloquine chemoprophylaxis.
    Croft AM; World MJ
    Lancet; 1996 Feb; 347(8997):326. PubMed ID: 8569381
    [No Abstract]   [Full Text] [Related]  

  • 9. Malaria and mefloquine prophylaxis use among Japan Ground Self-Defense Force personnel deployed in East Timor.
    Fujii T; Kaku K; Jelinek T; Kimura M
    J Travel Med; 2007; 14(4):226-32. PubMed ID: 17617844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mefloquine and doxycycline malaria prophylaxis in Australian soldiers in East Timor.
    Kitchener SJ; Nasveld PE; Gregory RM; Edstein MD
    Med J Aust; 2005 Feb; 182(4):168-71. PubMed ID: 15720172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Better approach needed to detect and treat military personnel with adverse effects from mefloquine.
    Quinn JC
    BMJ; 2016 Feb; 352():i838. PubMed ID: 26865279
    [No Abstract]   [Full Text] [Related]  

  • 12. [Malaria chemoprophylaxis: tolerance and compliance with mefloquine and proguanil/chloroquine combination in French tourists].
    Carme B; Péguet C; Nevez G
    Bull Soc Pathol Exot; 1997; 90(4):273-6. PubMed ID: 9479468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term malaria prophylaxis with mefloquine: a study of adverse drug reactions].
    El Jaoudi R; Benziane H; Khabbal Y; Elomri N; Lamsaouri J; Cherrah Y
    Therapie; 2010; 65(5):439-45. PubMed ID: 21144479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerance of mefloquine chemoprophylaxis in Dutch military personnel.
    Jaspers CA; Hopperus Buma AP; van Thiel PP; van Hulst RA; Kager PA
    Am J Trop Med Hyg; 1996 Aug; 55(2):230-4. PubMed ID: 8780466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of contraindications to mefloquine use among USA military personnel deployed to Afghanistan.
    Nevin RL; Pietrusiak PP; Caci JB
    Malar J; 2008 Feb; 7():30. PubMed ID: 18267019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mefloquine for malaria prophylaxis in military personnel.
    Williamson V; Blamey H; Sharpley J; David A; Greenberg N
    BMJ Mil Health; 2020 Nov; 166(E):e1-e2. PubMed ID: 32086266
    [No Abstract]   [Full Text] [Related]  

  • 17. Mefloquine as a prophylaxis for malaria needs to be revisited.
    Ahmad SS; Rahi M; Ranjan V; Sharma A
    Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():23-26. PubMed ID: 34339933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuropsychiatric side effects of malarial prophylaxis with mefloquine (Lariam)].
    Minei-Rachmilewitz T
    Harefuah; 1999 Jul; 137(1-2):25-7, 87. PubMed ID: 10959270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychiatric events during prophylactic use of mefloquine before travelling.
    van Riemsdijk MM; Ditters JM; Sturkenboom MC; Tulen JH; Ligthelm RJ; Overbosch D; Stricker BH
    Eur J Clin Pharmacol; 2002 Sep; 58(6):441-5. PubMed ID: 12242605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychiatric Outcomes After Mefloquine Exposure Among U.S. Military Service Members.
    Eick-Cost AA; Hu Z; Rohrbeck P; Clark LL
    Am J Trop Med Hyg; 2017 Jan; 96(1):159-166. PubMed ID: 28077744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.